Hyperlipidemia, Familial CombinedHypertensionHyperlipidemiasMetaraminolAcute DiseaseHypertension, RenalBlood PressureSodium-Phosphate Cotransporter Proteins, Type IIEvans BlueBlood-Brain BarrierPia MaterSodium-Hydrogen AntiporterHypertension, PulmonaryRats, Sprague-DawleyAngiotensin IICerebrovascular CirculationVasoconstrictor AgentsKidney Tubules, ProximalTriglyceridesRats, Inbred StrainsHypolipidemic AgentsLipidsCholesterolHypertension, PortalAntihypertensive AgentsRisk FactorsHypertriglyceridemiaCholesterol, LDLHypertension, RenovascularHypercholesterolemiaHyperlipoproteinemia Type IVLipoproteinsApolipoproteins EHypertension, MalignantLipid MetabolismCholesterol, HDLApolipoproteins BApolipoproteins CApolipoprotein E2ObesityApolipoprotein C-IIIFenofibrateLipoprotein LipaseArteriosclerosisXanthomatosisLipoproteins, VLDLAnticholesteremic AgentsDiabetes MellitusHydroxymethylglutaryl-CoA Reductase InhibitorsLiverCardiovascular DiseasesApolipoproteinsLipoproteins, LDLDisease Models, AnimalCholesterol, VLDLAtherosclerosisDietary FatsGynostemmaBody WeightHyperlipoproteinemia Type IIHypertension, Pregnancy-InducedReceptors, LDLBlood GlucoseDiabetes Mellitus, Type 2DyslipidemiasPrevalenceInsulin ResistanceHyperlipoproteinemia Type IIITime FactorsMice, Inbred C57BLKidneyPoloxamerHeptanoic AcidsTreatment OutcomeDiet, AtherogenicOcular HypertensionApolipoprotein A-IPulmonary ArteryCholesterol, DietaryDiabetes ComplicationsAge FactorsRetrospective StudiesInsulinFatty LiverPostprandial PeriodSimvastatinBezafibratePyrrolesMice, KnockoutEpichlorohydrinRats, Inbred SHRFollow-Up StudiesApolipoproteins AProspective StudiesReninNephrotic SyndromeHyperlipoproteinemiasAortaIntracranial HypertensionSex Factors